Publication | Closed Access

Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade

Alzheimer's DiseasePhosphatidylinositol 3-Kinase CascadeDementiaMedicineNicotineAcetylcholinesterase InhibitorsNeuropharmacologyNeurochemical BiomarkersNeuroprotectionNeurologyNeuroscienceNeurodegenerationNicotinic Acetylcholine ReceptorsMolecular NeurobiologyPharmacologyNeurochemistryTreatment